The UV Filter Dilemma: Regulatory Constraints, Particle Physics, and the Real-World SPF Gap
How Regulation Narrows the Filter Palette Before the Chemistry Begins
Title graphic contrasting the 17 UV filters permitted in the United States against the 28 authorized in the European Union, with mineral, organic and EU-exclusive photostable filters shown as a particle field and UV breaking through the sparser US side

Why This Matters Now

A sunscreen brand with strong sales in the European market decides to expand into the United States. Their flagship product uses bemotrizinol, a broad-spectrum UV filter with excellent photostability and a cosmetically elegant sensory profile. It has been approved in Europe for over a decade. In the United States, until very recently, it was not permitted at all.

So the brand reformulates for the US market, replacing bemotrizinol with avobenzone, the only organic UVA filter with GRASE status from the FDA. Avobenzone, however, is photounstable. Without a photostabilizer, it degrades rapidly under UV exposure, losing most of its protective efficacy within a few hours of sunlight. The formulator adds octocrylene to address this. Then they receive a request from a major retail partner: the product must also meet Hawaii’s reef-safe requirements, which prohibit both oxybenzone and octinoxate. Octocrylene is not banned, but its environmental profile is under increasing scrutiny. The sensory properties also need to align with what US consumers expect from a premium facial sunscreen.

Eighteen months later, the brand has a product that works in the US market. It is not quite as elegant as the European version, not quite as photostable, and costs more to make. This is not an unusual situation. It reflects a constraint that operates upstream of the formulation itself: regulation that determines which UV filters are available before the chemistry begins.

A recent FastFormulator article, How Modern Sunscreen Trends Are Forcing a Rethink of Formulation Design, examined the market forces reshaping the sun care category and identified three physicochemical properties at the center of the problem: shear-thinning rheology, surface tension and interfacial behavior, and colloidal stability. This article builds on that foundation. Where the first piece established the landscape, this one goes further upstream into the regulatory environment that determines which UV filters are on the table before any formulation decisions are made, and then deeper into specific mechanisms the first article introduced but did not fully explore: the photocatalytic behavior of uncoated mineral particles, particle size distribution as a skin tone inclusivity problem, and the gap between standardized SPF measurements and real-world protection through film continuity.

A Regulatory System That Shapes Formulation Before the Chemistry Begins

No other category in personal care is as tightly constrained by regulation before the formulation work even starts. In the United States, sunscreens are classified as over-the-counter drugs, meaning any active ingredient must achieve GRASE status through the FDA’s OTC monograph process. As of early 2026, only 17 UV filters are permitted in the US, and of those, only zinc oxide and titanium dioxide hold unconditional GRASE status among mineral filters. The FDA approved its first new UV filter in over two decades only in mid-2026, when bemotrizinol finally cleared the regulatory pathway established by the CARES Act.

The European Union takes a different approach, classifying sunscreen filters as cosmetic ingredients subject to the EU Cosmetics Regulation. This allows faster market access through safety dossier review, and 28 UV filters are currently authorized in the EU.

Side-by-side comparison of the US and EU UV filter regimes: 17 filters permitted under the FDA's OTC drug GRASE process versus 28 authorized as cosmetic ingredients in the EU, with a timeline of regulatory milestones from Hawaii's 2021 ban to the FDA's 2026 approval of bemotrizinol

The disparity has real formulation consequences. Filters available in Europe and widely used in Asian markets, such as Tinosorb S, Tinosorb M, and Mexoryl SX, offer superior photostability, broader UV coverage, and more elegant sensory profiles than their US-permitted equivalents. Brands selling globally must either maintain separate formulations for different markets or accept the constraints of the most restrictive regulatory environment.

Reef protection legislation adds another layer. Hawaii banned sunscreens containing oxybenzone and octinoxate in 2021, the first such law in the United States, and Maui County extended this to a full use ban in 2022. Other jurisdictions have followed, and the regulatory momentum continues. For brands positioning themselves as environmentally responsible, the pressure to reformulate away from established chemical filter systems is significant even where formal bans do not yet exist.

By the time a sunscreen formulator sits down to design a product, a substantial portion of the formulation space has already been eliminated by regulation, retailer requirements, and consumer expectations. The remaining filters must then be made to work across a set of physicochemical challenges that are among the most demanding in the industry.

The Distinct Physics of UV Filters

Understanding sunscreen formulation requires understanding that the two broad categories of UV filter, organic and inorganic, operate through fundamentally different physical mechanisms and introduce fundamentally different formulation problems.

Comparison of organic and inorganic UV filters, contrasting absorption of UV photons against scattering and reflection, with photodegradation of avobenzone as the core challenge for organic filters and particle physics, sedimentation and white cast as the core challenge for mineral filters

Organic Filters: Absorption, Photostability, and the Coupling Problem

Organic UV filters work by absorbing UV radiation and releasing energy as heat, each tuned to a specific wavelength range. A broad-spectrum formulation requires a blend covering both UVA and UVB, with multiple filter molecules coexisting in the oil phase. The photostability challenges of organic filters, including the avobenzone/octocrylene dependency and its formulation consequences, were covered in the previous FastFormulator article. The regulatory dimension adds a layer that the bench chemistry alone cannot resolve: US formulators have effectively been forced into that dependency for decades because the more photostable alternatives widely used in Europe, including bemotrizinol, bisoctrizole, and Mexoryl SX, were not permitted under the FDA’s OTC monograph framework. Avobenzone’s photostability problem is not simply a chemistry problem. It is a regulatory problem with chemistry consequences, and the June 2026 FDA approval of bemotrizinol, the first new UV filter permitted in the United States in over two decades, signals that the constraint may finally be loosening.

The interaction between organic filters and the rest of the formulation is not limited to the oil phase. UV filters can interact with emulsifiers and polymers, shifting the pH of the system over time as degradation products accumulate. A filter blend that is stable at the time of manufacture may destabilize an emulsion over a 12-month shelf life. The relationship between filter concentration, photostabilizer ratio, emulsifier selection, and long-term emulsion integrity is a coupled system that does not simplify to a linear optimization problem.

Inorganic Filters: Dispersion, White Cast, and Particle Physics

Zinc oxide and titanium dioxide protect through a different mechanism, primarily scattering and reflecting UV radiation rather than absorbing it. They are broad-spectrum by nature, covering both UVA and UVB with a single ingredient, which simplifies the regulatory picture considerably. They are also among the most consumer-trusted filter options, particularly for sensitive skin, infant skin, and reef-conscious consumers. Their formulation challenges are substantial, however, and they originate in the physics of particles.

Both ZnO and TiO2 are dense inorganic solids with high surface area when used at the particle sizes required for effective UV attenuation. Particle size governs the tradeoff between optical performance and cosmetic elegance.

Particle size spectrum for mineral UV filters from 20 nm to over 500 nm, comparing UV efficacy, white cast, transparency, regulatory status and consumer concern across the nano, transition and bulk zones, with a note on how white cast disproportionately reduces real-world SPF for deeper skin tones

Larger particles, above roughly 100 nm, scatter visible light as well as UV radiation, producing the characteristic white cast that has historically made mineral sunscreens cosmetically unacceptable for many skin tones. Nanosized particles, in the 30 to 50 nm range, are more transparent to visible light while retaining UV scattering efficacy, but they carry regulatory uncertainty in some markets and consumer concern around nanoparticle safety, despite the substantial evidence base supporting their safety in topical applications.

Surface treatment is critical for both performance and stability. Uncoated titanium dioxide is photocatalytically active under UV exposure, generating reactive oxygen species that degrade organic co-formulants, including emulsifiers, UV filters, and preservatives. Silica, alumina, and stearic acid coatings reduce this photocatalytic activity, but the thickness, coverage, and chemistry of the coating also determine how the particle disperses in oil or water phases, how it interacts with emulsifier systems, and how resistant it is to aggregation during storage. A particle with a silicone-based surface coating behaves differently in a water-in-oil emulsion than in an oil-in-water system, and reformulating between the two emulsion types requires revisiting the entire particle surface treatment strategy. ZnO carries an additional sedimentation challenge: at approximately 5.6 g/cm³, it is more than five times denser than water, and the yield stress required to resist gravitational settling competes directly with consumer expectations of a lightweight feel.

Critical Properties in Sunscreen Formulation

The physicochemical properties governing sunscreen performance span the full range of what makes any emulsion-based product technically difficult, with the additional burden of UV filter physics.

Colloidal Stability Under UV Stress

The previous FastFormulator article established the mechanisms of colloidal stability in sunscreen formulations: the balance of van der Waals attractive forces and repulsive steric or electrostatic forces, the role of surface treatment chemistry, and the aggregation failure modes that emerge months into shelf-life testing. What the UV exposure dimension adds is specific to this category. A sunscreen is a colloidal dispersion that is specifically designed to be exposed to the conditions that most accelerate colloidal degradation: UV radiation, elevated temperature, and repeated application and removal. The emulsifier system must maintain droplet integrity not just during storage but during the product’s active use conditions.

Photodegradation of emulsifiers at the oil-water interface is a real failure mode, particularly in formulations where the UV filter is inadequately positioned to protect the interface. Organic filter degradation products can shift local pH at the droplet surface, disrupting electrostatic stabilization. In mineral-heavy formulations, particle aggregation during UV exposure can create large agglomerates that produce uneven coverage and visible white patches on skin. Stability testing protocols for sunscreens must therefore include UV exposure conditions as well as temperature cycling, which extends the testing timeline compared to standard cosmetic products.

Rheology: Suspending Particles While Remaining Spreadable

The previous FastFormulator article established the core rheological challenge of mineral sunscreens: balancing shear-thinning behavior across the storage, dispensing, and application regimes, and managing the yield stress and structural recovery that determine whether a film spreads cleanly or streaks. The mineral loading dimension sharpens those challenges at the concentrations required for SPF 30 and above. The formulation must hold sufficient yield stress to suspend dense ZnO or TiO2 particles during storage, while dropping in viscosity sharply enough during application to spread across skin without drag. Adjusting the thickener concentration to improve particle suspension typically increases mid-shear viscosity during spreading, making the product feel heavier. Reducing thickener for a lighter feel risks sedimentation in the bottle.

ZnO and TiO2 particles, at the concentrations required for SPF 30 or above, increase the zero-shear viscosity of the system significantly. The polymer and thickener framework that produces appropriate rheology in an unloaded emulsion requires reformulation when mineral particles are incorporated at high loading, because the particles contribute to the structural network as well as to viscosity. For brands shifting from organic filter systems to mineral-only formulations to meet reef-safe or GRASE compliance requirements, this means the rheological engineering is not a minor adjustment but a rebuild from the structural baseline up.

Surface Tension and Film Continuity

The SPF value of a sunscreen is measured under standardized laboratory conditions using a defined application rate, typically 2 mg/cm² of skin surface. Real-world SPF is consistently lower than the label value because consumers apply sunscreen at lower rates and less uniformly. The dynamic surface tension of the formulation governs how quickly and how completely it wets the skin surface during application, and film continuity after spreading determines whether UV protection is uniform or patchy.

A formulation with high dynamic surface tension resists rapid spreading, leaving thicker deposits in some areas and thinner deposits in others. Emulsifiers and skin-conditioning agents that reduce dynamic surface tension improve film uniformity, which translates directly into more consistent protection. In hybrid SPF-cosmetic products, where the sunscreen is also providing coverage from pigments or color correction, the wetting behavior must be tuned simultaneously for film formation and optical performance.

Particle Size Distribution and the White Cast Tradeoff

The optical performance of a mineral sunscreen is a function of particle size distribution, particle concentration, and the refractive index difference between the particles and the surrounding medium. For titanium dioxide, which has a very high refractive index, even small changes in particle size distribution shift the UV absorption profile and the visible light scattering behavior. Achieving consistent SPF across product batches requires tight control of particle size distribution from the dispersion step through filling and packaging.

For darker skin tones, the white cast from mineral filters is a substantial barrier to product use, reducing real-world protection in populations who may benefit from it most. Tinted mineral sunscreens incorporating iron oxides partially address this, but adding a pigment phase introduces another dispersed system that must remain stable alongside the ZnO or TiO2, with optical properties balanced against the mineral filter.

Why These Properties Cannot Be Solved Independently

The previous FastFormulator article established that the three core properties (rheology, interfacial behavior, and colloidal stability) cannot be optimized independently, and that adjustments to one typically shift at least two others. The scenario below shows how regulatory constraints feed directly into that coupling problem, narrowing the available filter chemistry in ways that shift every downstream formulation decision simultaneously.

Diagram of the coupling between rheology, colloidal stability and surface tension in a mineral sunscreen, with mineral loading, particle size, surface treatment chemistry and emulsifier choice as the shared levers, all constrained upstream by the regulatory filter palette

Consider the challenge of developing a reef-safe, mineral SPF 50 product for diverse skin tones that meets both FDA and EU requirements and maintains stability over 24 months. The constraint set immediately narrows the available chemistry: ZnO as the primary filter, with no oxybenzone, no octinoxate, and limited options for other organic co-filters. To achieve SPF 50 with ZnO alone requires high particle loading, which drives up viscosity and yield stress, producing a product that is difficult to spread and leaves a heavy, white deposit. Reducing particle size toward the nano range improves transparency but introduces regulatory and consumer communication challenges. Surface-treating the particles to reduce photocatalytic activity and improve dispersion changes their interaction with the emulsifier, potentially destabilizing the emulsion. Adding a thickener to manage rheology under the high mineral load affects the dynamic surface tension and film formation behavior, which affects real-world SPF. Incorporating iron oxides for a tinted finish adds a third particulate phase that must be co-dispersed and co-stabilized with the ZnO.

Each of these variables affects multiple properties simultaneously. Solving for one typically shifts at least two others. The design space for a product that satisfies all of these constraints is narrow, and identifying it through purely sequential experimental work is slow and resource-intensive.

Where Predictive Tools Change the Approach

FastFormulator’s Virtual Viscometer, Virtual Surface Tensiometer, and Virtual Stability Chamber were introduced in the previous article as tools for addressing the three core physicochemical challenges in sunscreen formulation. In regulatory-constrained development, including mineral-only systems, reef-safe requirements, and simultaneous US and EU compliance, their value is sharpened by the narrowness of the available design space. When the filter palette is restricted by GRASE status or environmental legislation, and a stability failure at the six-month mark cannot be resolved simply by swapping to an alternative filter blend, the cost of late-stage failure is substantially higher than in less constrained categories.

Traditional development cycles are sequential: formulation preparation, then months of stability testing, then accredited SPF measurement, then sensory evaluation. When a formulation fails at the 6-month stability timepoint, development has consumed at least six months before the failure is detected. For brands targeting simultaneous US, EU, and reef-safe compliance across multiple skin tones, the number of candidate formulations that need testing is large, and the sequential approach scales poorly. Predictive tools built on chemistry-aware modeling offer a different entry point: models trained on physicochemical data can provide early estimates of how compositional choices, particle surface treatments, emulsifier selections, and mineral concentrations will affect viscosity, colloidal stability, and interfacial behavior before the first batch is prepared, allowing teams to screen computationally and focus experimental resources on the two or three candidates most likely to succeed.

Applied to sunscreen specifically: for mineral-heavy systems, the Virtual Viscometer predicts how ZnO or TiO2 loading and surface treatment affect viscosity before scale-up, avoiding costly reformulation at later stages. The Virtual Stability Chamber identifies which emulsifier-filter combinations are most likely to maintain colloidal integrity under UV stress conditions, narrowing the experimental field significantly. The Virtual Surface Tensiometer supports more deliberate film formation design by predicting how dynamic wetting properties shift with different emollient and surfactant selections rather than discovering those shifts through empirical trial and error.

The intersection of UV filter physics and cosmetic performance becomes even more complex in hybrid SPF-foundation products, where mineral particle dispersion, pigment stability, long-wear film formation, and shade consistency across 40 or more formulations must all be solved simultaneously.

Takeaways

Building on the previous FastFormulator article, this article has traced the reformulation pressures reshaping sun care to their upstream source: the regulatory environment that determines which UV filters are available before formulation work begins. The FDA’s OTC drug classification framework, and the GRASE process that governs US market access, has meant that US formulators have operated with a narrower filter palette for decades while European counterparts had access to more photostable alternatives. The June 2026 approval of bemotrizinol, the first new UV filter in the US market in over two decades, signals that this may be changing. The shift toward mineral-only and reef-safe formulations, driven by Hawaii’s legislation and consumer preference, has narrowed the toolkit further while simultaneously raising expectations for performance and cosmetic elegance across diverse skin tones.

The difficulty is that the critical properties in sunscreen formulation, colloidal stability, rheological profile, surface tension and film uniformity, and particle size distribution, are tightly coupled through the physics of the system. Increasing mineral filter concentration to achieve higher SPF raises viscosity and challenges suspension stability. Surface treating particles to prevent photocatalytic degradation changes how they interact with the emulsifier. Reducing particle size to minimize white cast introduces different surface chemistry and different dispersion behavior. Every variable in the formulation influences multiple performance outcomes, and the design space that satisfies all constraints simultaneously is narrow enough that empirical trial-and-error exploration is both slow and expensive.

Predictive tools built on chemistry-aware modeling can substantially reduce the cost of navigating this design space by providing early estimates of how formulation choices affect stability, viscosity, and film behavior before experimental resources are committed. In a category where a single formulation must satisfy regulators in multiple markets, perform under active UV exposure conditions, and remain cosmetically acceptable across a range of skin tones, the ability to identify the most promising candidates before committing to the full development cycle is not just operationally valuable; it is increasingly a prerequisite for competitive product development.

References

  • Shaath, N.A. (Ed.) (2005). Sunscreens: Regulations and Commercial Development, 3rd Edition. Taylor & Francis, Boca Raton.
  • Serpone, N., Donkova, B., Kaneva, N. and Nicklen, C.S. (2013). Titanium dioxide and zinc oxide nanoparticles in sunscreens: focus on their safety and effectiveness. Nanotoxicology, 7(3), 252–259.
  • Diffey, B.L. (2001). When should sunscreen be reapplied? Journal of the American Academy of Dermatology, 45(6), 882–885.
  • Sayre, R.M., Dowdy, J.C. and Gerwig, A.J. (2004). Photodegradation of avobenzone: stabilization with octocrylene and Tinosorb. Journal of the American Academy of Dermatology, 55(2), Suppl, S165–S173.
  • Nohynek, G.J. and Dufour, E.K. (2012). Nano-sized cosmetic formulations or solid nanoparticles in sunscreens: a risk to human health? Archives of Toxicology, 86(7), 1063–1075.
  • Ioele, G., De Luca, M. and Ragno, G. (2021). Photoprotective cosmetics: regulatory overview and formulation strategies. Cosmetics, 8(1), 1–22.
  • Grand View Research (2024). Sun Care Products Market Size, Share & Trends Analysis Report, 2024–2030.
  • Mitchnick, M.A., Fairhurst, D. and Pinnell, S.R. (1999). Microfine zinc oxide (Z-Cote) as a photostable UVA/UVB sunblock agent. Journal of the American Academy of Dermatology, 40(1), 85–90.
  • Vielhaber, G. and Schneider, G. (1999). Photostabilizers for ultraviolet-A sunscreens. Cosmetics and Toiletries, 114(7), 65–72.
  • U.S. Food and Drug Administration (2026). FDA Expands Sunscreen Options: Approval of Bemotrizinol Under the OTC Monograph Process. FDA.gov.